Merck (MRK) Short term Debt (2009 - 2026)

Merck (MRK) has 18 years of Short term Debt data on file, last reported at $2.4 billion in Q1 2026.

• Short term Debt for Q1 2026 came in at $2.4 billion, up 79.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 billion (up 79.71% YoY), and the FY2025 annual result was $2.6 billion, down 2.27% from the prior year.
• Short term Debt eased to $2.4 billion in Q1 2026 per MRK's latest filing, from $2.6 billion in the prior quarter.
• Over five years, Short term Debt peaked at $3.1 billion in Q3 2024 and troughed at $887.0 million in Q3 2023.
• A 5-year average of $2.2 billion and a median of $2.4 billion in 2026 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2022 and 2024: Short term Debt plunged 83.34% in 2022, then jumped 255.02% in 2024.
• A 5-year view of Short term Debt shows it stood at $1.9 billion in 2022, then decreased by 29.5% to $1.4 billion in 2023, then surged by 93.08% to $2.6 billion in 2024, then fell by 2.27% to $2.6 billion in 2025, then dropped by 5.6% to $2.4 billion in 2026.
• Business Quant data shows MRK's Short term Debt at $2.4 billion in Q1 2026, $2.6 billion in Q4 2025, and $1.4 billion in Q3 2025.